Symptomatic endpoint responder rates to BAROSTIM Therapy
نویسندگان
چکیده
منابع مشابه
Distribution of Circulating Immune Cells in Responder and Non-Responder Individuals to Hepatitis B Vaccine
Unresponsiveness to hepatitis B surface antigen (HBsAg) has been shown to be associated with dysfunction of the presenting cells (APC) and defect in the specific B-lymphocyte and/or T-lymphocyte repertoires. Direct determination of the frequency of specific T-lymphocytes together with complementary analysis of the naive circulating immune cells could provide valuable information about the cel...
متن کاملCost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.
OBJECTIVE The purpose of this study is to simulate the cost-effectiveness and the long-term clinical performance of the Barostim neo System for the treatment of resistant hypertension when compared to optimal medical treatment. METHODS A decision analytic model with a combination of a decision tree and Markov process was used to evaluate the cost-effectiveness of Barostim. The clinical effect...
متن کاملProgesterone Therapy for Symptomatic Perimenopause
Learning Objectives: 1. Perimenopause, although characterized as a time of dropping estradiol, involves chaotic estrogen levels that average >20% higher and intermittently are extremely high and ovulatory disturbances with decreasing progesterone levels. 2. Perimenopause begins and is most symptomatic when cycles remain regular. 3. Perimenopause is highly symptomatic for more than 20% of women—...
متن کاملSymptomatic impact of testosterone therapy
Background: relative androgen deficiency in ageing males is assumed to have adverse health effects. This study assessed the effect of 12 months’ standard dose, oral testosterone, on symptoms attributed to testosterone deficiency in older men with plasma testosterone levels in the low–normal range for young men. Methods: testosterone undecanoate (TU, 80 mg bid) or placebo was administered for on...
متن کاملSymptomatic therapy in multiple sclerosis.
Multiple sclerosis is the most common disabling neurological disease of young adults. The ability to impact the quality of life of patients with multiple sclerosis should not only incorporate therapies that are disease modifying, but should also include a course of action for the global multidisciplinary management focused on quality of life and functional capabilities.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2020
ISSN: 0195-668X,1522-9645
DOI: 10.1093/ehjci/ehaa946.1119